Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) improved of late. NBIX’s current Value Trend Rating is B and the prior Rating was […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Brown & Brown Inc (NYSE: BRO) weakened in recent days. BRO’s current Value Trend Rating is C and the prior […]
Stock Rating Upgrade The Value Trend Rating for Novo Nordisk A/S (NYSE: NVO) improved of late from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Ark Restaurants Corp. (NASDAQ: ARKR) fell significantly in recent days. ARKR’s current Value Trend Rating is F and the prior […]
Stock Rating Downgrade Of late the Value Trend Rating for Adobe Inc (NASDAQ: ADBE) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Adobe Inc (NASDAQ: ADBE) stock closed […]
Nelnet Inc. (NYSE: NNI) suffers from significant negative changes in fundamentals: the consensus estimate for December, 2023 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Nelnet Inc. […]
Stock Rating Downgrade During the last several trading days the Value Trend Rating for Companhia de Saneamento Basico d (NYSE: SBS) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price […]
Recent extremely meaningful negative changes in fundamentals have impacted Gerdau SA (NYSE: GGB): the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and significant […]
Stock Rating Downgrade The Value Trend Rating for Manhattan Bridge Capital (NASDAQ: LOAN) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Catalyst Biosciences Inc (NASDAQ: CBIO) stock closed at $22.51 on 1/12/24 after a major decline of -14.6%. However, this decline was accompanied by unusually low trading volume at 58% of normal. The stock has been […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research